HEAL Deadline: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics]
Tuesday, October 11, 2022, 8:00 AM EDT
Category: NIH
Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)RFA-NS-21-029 Multidisciplinary team and obtain preliminary data to establish feasibility for a future U19 project through a 2-year planning grant Upcoming Receipt Date: October 11, 2022 Program Contact: Julia L. Bachman, PhD Email: [email protected] |